Clinical characteristics and prognosis of orbital solitary fibrous tumor in patients from a Chinese tertiary eye hospital
Open Access
- 26 September 2022
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 10 (27), 9670-9679
- https://doi.org/10.12998/wjcc.v10.i27.9670
Abstract
Solitary fibrous tumor (SFT) is predominant within the pleura but very rare in the orbit, which is why the diagnosis of orbital SFT poses challenges in clinical practice. Accordingly, an integrated approach that incorporates specific clinical features, histological, histopathological, and immunohistochemical (IHC) examinations, and molecular analyses is warranted. To retrospectively explore the clinical and imaging characteristics, treatment, outcomes of a series of patients with orbital SFT. We conducted a retrospective review of a series of patients diagnosed with a histopathologic orbital SFT treated at a single institution. All data on demogra phics, clinical characteristics, imaging, treatment, postoperative histopathological and IHC examinations, and prognosis were collected. In total, 13 patients were enrolled, 7 (53.8%) of whom had the tumor located in the superomedial quadrant of the orbit. Computed tomography revealed a solitary ovoid lesion in 10 (76.9%) patients and irregular lesion in 3 (23.1%) patients. Magnetic resonance imaging results were as follows: On T1 weighted images, 3 (23.1%) patients had hypointense mixed signals, whereas 10 (76.9%) patients showed isointense mixed signals; on T2 weighted images (T2WI), 3 (23.1%), 4 (30.8%), and 6 (46.2%) patients exhibited hypointense mixed, isointense mixed, and hyperintense signals, respectively. Notably, 12 (92.3%) patients showed significant enhancement, whereas there were patchy slightly enhanced areas in the tumor. All patients were treated by surgery. IHC analysis demonstrated that the tumor cells were immunoreactive for CD34, CD99, STAT-6, and vimentin in all patients. The lesions showed Ki-67 positivity < 5% in 1 (7.7) patient, 5%-10% in 10 (76.9%), and > 10% in 2 (15.4%). Two (15.4%) patients exhibited tumor recurrence. The clinical manifestations and radiologic characteristics of orbital SFT are diverse and not specific. Accurate diagnosis and treatment require detailed radiological and histopathological/ IHC evaluation.Keywords
This publication has 20 references indexed in Scilit:
- Solitary fibrous tumor of the orbitJournal of Cancer Research and Therapeutics, 2019
- Solitary Fibrous Tumors of the Head and NeckThe American Journal of Surgical Pathology, 2017
- Solitary fibrous tumor of the orbit: Case report and review of the literatureJournal Français d'Ophtalmologie, 2017
- Total resection combined with osteotomy is more effective for orbital solitary fibrous tumor excision: a report of three casesInternational Ophthalmology, 2017
- Recurrent Orbital Solitary Fibrous Tumor in a 12-Year-OldOcular Oncology and Pathology, 2016
- The clinicopathological significance of NAB2‐STAT6 gene fusions in 52 cases of intrathoracic solitary fibrous tumorsCancer Medicine, 2015
- Ki67 is a promising molecular target in the diagnosis of cancer (Review)Molecular Medicine Reports, 2014
- Solitary fibrous tumor of the orbit: a case report and review of literatureTurkish Neurosurgery, 2014
- Solitary fibrous tumor: an update on the spectrum of extrapleural manifestationsSkeletal Radiology, 2010
- Solitary Fibrous Tumor of the Orbit: CT and MR Imaging FindingsAmerican Journal of Neuroradiology, 2008